Survival still poor in non-clear cell RCC despite targeted therapies

Even in the era of targeted therapy, most patients with non-clear cell renal cell carcinoma still have inferior survival compared with their clear-cell counterparts, despite outcomes being significantly improved, study findings indicate.

via Med Wire News